The Artificial Pancreas in Very Young Children With T1D

NACompletedINTERVENTIONAL
Enrollment

81

Participants

Timeline

Start Date

May 1, 2019

Primary Completion Date

February 22, 2021

Study Completion Date

October 3, 2022

Conditions
Type 1 Diabetes Mellitus
Interventions
DEVICE

CamAPS FX

"CamAPS FX closed loop system comprises:~* Dana insulin pump (Diabecare, Sooil, Seoul, South Korea)~* Dexcom G6 real-time CGM sensor (Dexcom, Northridge, CA, USA)~* An Android smartphone hosting CamAPS FX app with the Cambridge model predictive control algorithm and communicating wirelessly with the insulin pump and glucose sensor~* Cloud upload system to monitor CGM/insulin data"

OTHER

Sensor augmented therapy

Study insulin pump and study CGM.

Trial Locations (8)

A-8036

Medical University of Graz Department of Pediatrics and Adolescent Medicine, Graz

A-6020

Medical University of Innsbruck Department of Pediatrics I, Innsbruck

A-1090

Medical University of Vienna Department of Pediatrics, Vienna

D-04103

University of Leipzig Division for Paediatric Diabetology, Leipzig

L-1210

Clinique Pédiatrique de Luxembourg Centre Hospitalier de Luxembourg, Luxembourg

CB2 0QQ

University Department of Paediatrics, Cambridge

Wellcome Trust-MRC Institute of Metabolic Science University of Cambridge, Cambridge

LS9 7TF

St James's University Hospital, Leeds

Sponsors
All Listed Sponsors
collaborator

European Commission

OTHER

collaborator

Cambridge University Hospitals NHS Foundation Trust

OTHER

collaborator

The Leeds Teaching Hospitals NHS Trust

OTHER

collaborator

University of Luxembourg

OTHER

collaborator

University of Leipzig

OTHER

collaborator

Medical University of Graz

OTHER

collaborator

Medical University Innsbruck

OTHER

collaborator

Medical University of Vienna

OTHER

collaborator

Jaeb Center for Health Research

OTHER

collaborator

University of Edinburgh

OTHER

collaborator

Stanford University

OTHER

collaborator

Glooko

INDUSTRY

lead

University of Cambridge

OTHER